Literature DB >> 12783570

Minidefensins and other antimicrobial peptides: candidate anti-HIV microbicides.

Alexander M Cole1.   

Abstract

Antimicrobial peptides have long been presumed to act as effector molecules of innate immunity. However, direct evidence that antimicrobial peptides have central roles in host defence has only recently become available. An overview of the types and characteristics of endogenous human antimicrobial peptides and proteins is presented, with particular emphasis on peptides that are active against HIV. These antiviral peptides are discussed in the context of utilising natural peptides for the design of effective topical microbicides for the treatment of sexually transmitted infections (STIs). Several antimicrobial peptides, termed minidefensins, are potently active against HIV, and bear structural similarity to their larger defensin cousins. Strategies to develop potent peptide antibiotics based on defensin and minidefensin templates are promising in the development of antiviral therapeutics and preventatives.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12783570     DOI: 10.1517/14728222.7.3.329

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  7 in total

1.  Driving engineering of novel antimicrobial peptides from simulations of peptide-micelle interactions.

Authors:  Himanshu Khandelia; Allison A Langham; Yiannis N Kaznessis
Journal:  Biochim Biophys Acta       Date:  2006-05-15

2.  HIV-1 enhancing effect of prostatic acid phosphatase peptides is reduced in human seminal plasma.

Authors:  Julie A Martellini; Amy L Cole; Pavel Svoboda; Olga Stuchlik; Li-Mei Chen; Karl X Chai; Bhushan K Gangrade; Ole E Sørensen; Jan Pohl; Alexander M Cole
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

3.  Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides.

Authors:  Lars Steinstraesser; Bettina Tippler; Janine Mertens; Evert Lamme; Heinz-Herbert Homann; Marcus Lehnhardt; Oliver Wildner; Hans-Ulrich Steinau; Klaus Uberla
Journal:  Retrovirology       Date:  2005-01-18       Impact factor: 4.602

4.  Synergy Pattern of Short Cationic Antimicrobial Peptides Against Multidrug-Resistant Pseudomonas aeruginosa.

Authors:  Serge Ruden; Annika Rieder; Irina Chis Ster; Thomas Schwartz; Ralf Mikut; Kai Hilpert
Journal:  Front Microbiol       Date:  2019-11-28       Impact factor: 5.640

5.  Design and selection of peptides to block the SARS-CoV-2 receptor binding domain by molecular docking.

Authors:  Kendra Ramirez-Acosta; Ivan A Rosales-Fuerte; J Eduardo Perez-Sanchez; Alfredo Nuñez-Rivera; Josue Juarez; Ruben D Cadena-Nava
Journal:  Beilstein J Nanotechnol       Date:  2022-07-22       Impact factor: 3.272

6.  Reawakening retrocyclins: ancestral human defensins active against HIV-1.

Authors:  Nitya Venkataraman; Amy L Cole; Piotr Ruchala; Alan J Waring; Robert I Lehrer; Olga Stuchlik; Jan Pohl; Alexander M Cole
Journal:  PLoS Biol       Date:  2009-04-28       Impact factor: 8.029

7.  Rondonin: antimicrobial properties and mechanism of action.

Authors:  Katie C T Riciluca; Ursula C Oliveira; Ronaldo Z Mendonça; José C Bozelli Junior; Shirley Schreier; Pedro I da Silva Junior
Journal:  FEBS Open Bio       Date:  2021-08-19       Impact factor: 2.693

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.